Overview

Retinal arterial development in VEGF¹⁸⁸ mice is impaired. Homozygotes exhibit reduced fertility, smaller litter sizes and some prenatal lethality. This mutant mouse strain may be useful in studies of retinal angiogenesis.

Donating Investigator

Patricia D'Amore, Schepens Eye Research Institute

Genetic overview

Genetic Background	Generation

Vegfa^tm4Pec

Allele Type	Gene Symbol	Gene Name
Targeted	Vegfa	vascular endothelial growth factor A

View Genetics

Research Applications

Developmental Biology Research
Reproductive Biology Research
Sensorineural Research

View All Research Applications

Details

Detailed Description

Heterozygote: Heterozygote phenotype is similar to the wild-type phenotype.

Homozygote: Mice homozygous for the targeted mutation are viable, but exhibit reduced fertility, smaller litter sizes and some prenatal lethality. Surviving homozygotes gain less weight than wild-type controls. Retinal arterial development in VEGF¹⁸⁸ mice is impaired. By post natal day 5 (P5), only half the normal number of large vessels (mostly venules) are present in the vascular bed of the retina. By P9, arterioles are observed to be smaller in size and only 50% have developed and grown out over 17% of the retina. In controls, 88% of the retinal radius is covered by P9. Venous and capillary development appears normal.
VEGF¹⁸⁸ mice express a VEGF protein with all eight exons that avidly binds to the cell surface and extracellular matrix. This mutant mouse strain may be useful in studies of retinal angiogenesis.

Development

A targeting vector was designed to insert a loxP-flanked neomycin cassette into the 3' UTR of a cDNA containing fused exons 4 through 8. The construct was electroporated into (129X1/SvJ x 129S1/Sv)F1 derived R1 embryonic stem (ES) cells. Transient Cre expression in targeted cells excised the neo cassette. Correctly targeted ES cells were injected into blastocysts. The resulting chimeric animals were bred to C57BL/6 and then maintained by sibling mating. The VEGF¹⁸⁸ isoform contains all 8 exons. Upon arrival, mice were bred to C57BL/6J for at least 1 generation to establish the colony.

Selected References

Stalmans I; Ng YS; Rohan R; Fruttiger M; Bouche A; Yuce A; Fujisawa H; Hermans B; Shani M; Jansen S; Hicklin D; Anderson DJ; Gardiner T; Hammes HP; Moons L; Dewerchin M; Collen D; Carmeliet P; D'Amore PA. 2002. Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms. J Clin Invest 109(3):327-36PubMed: 11827992 MGI: J:75507

View All References

Genetics

Vegfa^tm4Pec

Allele Symbol: Vegfa^tm4Pec

Allele Name	targeted mutation 4, Peter Carmeliet
Allele Type	Targeted
Allele Synonym(s)	VEGF¹⁸⁸
Gene Symbol and Name	Vegfa, vascular endothelial growth factor A
Gene Synonym(s)
Promoter	Vegfa, vascular endothelial growth factor A, mouse, laboratory
Strain of Origin	(129X1/SvJ x 129S1/Sv)F1-Kitl⁺
Chromosome	17
Molecular Note	Genomic sequence containing exons 4 through 8 was replaced with corresponding cDNA. The resultant allele lacks splice sites and thereby produces a single isoform with high receptor binding properties. The exclusive presence of this isoform was verified by quatitative RT-PCR.
Mutations Made By	Dr. Peter Carmeliet, University of Leuven

Disease/Phenotype

Disease Terms

Model with phenotypic similarity to human disease where etiologies are distinct. Human genes are associated with this disease. Orthologs of these genes do not appear in the mouse genotype(s).

DiGeorge syndrome

Research Areas By Phenotype

This mouse can be used to support research in many areas including:

Developmental Biology Research
- Internal/Organ Defects
  - vasculature
Reproductive Biology Research
- Fertility Defects
Sensorineural Research
- Eye Defects

Mammalian Phenotype Terms by Genotype

The following phenotype information is associated with a similar, but not exact match to this JAX^® Mice strain

Genotype: Vegfa^tm4Pec/Vegfa^tm4Pec
involves: 129S1/Sv * 129X1/SvJ

cardiovascular system phenotype

abnormal arteriole morphology
- arterioles, but not venules, in the retina are smaller and extend over only 18% of the vascular bed (compared to 90% in controls)

abnormal blood vessel morphology
- about 50% of neonates exhibit severe DiGeorge syndome-like vessel malformations
- vascular defects are so severe in 19% of embryos that they cause circulatory collapse by E13.5

abnormal fourth pharyngeal arch artery morphology
- malformations of the 4th arch artery include a persistence of the carotid duct segment between the left carotid and subclavian artery and a descending aorta
- variable defects

abnormal pharyngeal arch artery morphology
- E14.5 embryos and neonates have remodeling defects of the 4th, 6th and, less frequently, 3rd pharyngeal arch arteries
- in E9.5 embryos, the arch arteries appear as primitive capillary networks, often with an irregular small lumen and signs of regression (19%)
- while the 3rd, 4th and 6th pharyngeal arch arteries are present by E10-10.5, subsequent malformations include hypoplasia, an irregular lumen size, and signs of regression in vessels that should normally persist

abnormal retinal vasculature morphology
- at P9, only half the normal number of arterioles develop, they are smaller in size, and grow out over only 17% of the retina
- capillary pruning is decreased, resulting in a more dense capillary bed and a slight increase in the number of periendothelial cells per retinal cell

abnormal sixth pharyngeal arch artery morphology
- variable defects

abnormal third pharyngeal arch artery morphology
- variable defects

abnormal vascular regression
- exhibit signs of regression in vessels of the pharyngeal arch that should normally persist

double aortic arch
- malformations of the 4th arch artery include a double aortic arch

interrupted aortic arch
- malformations of the 4th arch artery include type-B left 4th aortic arch interruption

persistent right dorsal aorta
- about 10% of embryos exhibit a dominant right dorsal aorta

persistent truncus arteriosis

pulmonary trunk hypoplasia
- hypoplasia of the pulmonary trunk

retroesophageal right subclavian artery
- malformations of the 4th arch artery include retroesophageal right subclavian artery

right aortic arch
- malformations of the 4th arch artery include a right-sided aortic arch

ventricular septal defect
- ventricular septal defect

cellular phenotype

abnormal vascular regression
- exhibit signs of regression in vessels of the pharyngeal arch that should normally persist

craniofacial phenotype

abnormal fourth pharyngeal arch artery morphology
- malformations of the 4th arch artery include a persistence of the carotid duct segment between the left carotid and subclavian artery and a descending aorta
- variable defects

abnormal pharyngeal arch artery morphology
- E14.5 embryos and neonates have remodeling defects of the 4th, 6th and, less frequently, 3rd pharyngeal arch arteries
- in E9.5 embryos, the arch arteries appear as primitive capillary networks, often with an irregular small lumen and signs of regression (19%)
- while the 3rd, 4th and 6th pharyngeal arch arteries are present by E10-10.5, subsequent malformations include hypoplasia, an irregular lumen size, and signs of regression in vessels that should normally persist

abnormal sixth pharyngeal arch artery morphology
- variable defects

abnormal third pharyngeal arch artery morphology
- variable defects

pharyngeal arch hypoplasia
- the first three pharyngeal arches are hypoplastic in 19% of E9.5 embryos

embryo phenotype

abnormal fourth pharyngeal arch artery morphology
- malformations of the 4th arch artery include a persistence of the carotid duct segment between the left carotid and subclavian artery and a descending aorta
- variable defects

abnormal pharyngeal arch artery morphology
- E14.5 embryos and neonates have remodeling defects of the 4th, 6th and, less frequently, 3rd pharyngeal arch arteries
- in E9.5 embryos, the arch arteries appear as primitive capillary networks, often with an irregular small lumen and signs of regression (19%)
- while the 3rd, 4th and 6th pharyngeal arch arteries are present by E10-10.5, subsequent malformations include hypoplasia, an irregular lumen size, and signs of regression in vessels that should normally persist

abnormal sixth pharyngeal arch artery morphology
- variable defects

abnormal third pharyngeal arch artery morphology
- variable defects

pharyngeal arch hypoplasia
- the first three pharyngeal arches are hypoplastic in 19% of E9.5 embryos

growth/size/body region phenotype

decreased body weight
- surviving mice gain less weight at 7 weeks of age

mammalian phenotype

respiratory system phenotype
- Normal - neonates display normal pulmonary development

mortality/aging

embryonic lethality during organogenesis, incomplete penetrance
- about half die between E9.5 and E13.5 and the rest survive for prolonged periods after birth

reproductive system phenotype

decreased litter size

reduced fertility
- fewer number of litters during 4 months

vision/eye phenotype

abnormal retinal vasculature morphology
- at P9, only half the normal number of arterioles develop, they are smaller in size, and grow out over only 17% of the retina
- capillary pruning is decreased, resulting in a more dense capillary bed and a slight increase in the number of periendothelial cells per retinal cell

References

Stalmans I; Ng YS; Rohan R; Fruttiger M; Bouche A; Yuce A; Fujisawa H; Hermans B; Shani M; Jansen S; Hicklin D; Anderson DJ; Gardiner T; Hammes HP; Moons L; Dewerchin M; Collen D; Carmeliet P; D'Amore PA. 2002. Arteriolar and venular patterning in retinas of mice selectively expressing VEGF isoforms. J Clin Invest 109(3):327-36PubMed: 11827992 MGI: J:75507

Additional - Vegfa^tm4Pec related

Technical Support

CONTACT TECHNICAL SUPPORT

Genotyping Protocols
- Standard PCR:Vegfa
- Genotyping resources and troubleshooting
Breeding Considerations

When maintaining a live colony, these mice can be bred as heterozygotes or homozygotes, however, homozygotes occur at a lower than Mendelian ratio (12%) than expected.
- Additional Breeding and Husbandry Support
Citation
When using the B6;129-Vegfa^tm4Pec/Mmjax mouse strain in a publication, please cite the originating article(s) and include MMRRC stock #34406 in your Materials and Methods section.

Animal Health Reports

Facility Barrier Level Descriptions

Production of mice from cryopreserved embryos or sperm occurs in a maximum barrier room, G200

The Jackson Laboratory's Genotype Promise

The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.

Terms Of Use

General Terms and Conditions

See MMRRC for Additional Conditions of Distribution

Questions about Terms of Use

Licensing Information

Phone: 207-288-6470

Email: TechTran@jax.org

JAX® Mice, Products & Services Conditions of Use

"MICE" means mouse strains, their progeny derived by inbreeding or crossbreeding, unmodified derivatives from mouse strains or their progeny supplied by The Jackson Laboratory ("JACKSON"). "PRODUCT(S)" means biological materials supplied by JACKSON, and their derivatives. "SERVICES" means projects conducted by JACKSON for other parties that may include but are not limited to the use of MICE or PRODUCTS. "RECIPIENT" means each recipient of MICE, PRODUCTS, or SERVICES provided by JACKSON including each institution, its employees and other researchers under its control. MICE or PRODUCTS shall not be: (i) used for any purpose other than internal research, (ii) sold or otherwise provided to any third party for any use, or (iii) provided to any agent or other third party to provide breeding or other services. Acceptance of MICE, PRODUCTS or SERVICES from JACKSON shall be deemed as agreement by RECIPIENT to these conditions, and departure from these conditions requires JACKSON’s prior written authorization.

No Warranty

MICE, PRODUCTS AND SERVICES ARE PROVIDED "AS IS". JACKSON EXTENDS NO WARRANTIES OF ANY KIND, EITHER EXPRESS, IMPLIED, OR STATUTORY, WITH RESPECT TO MICE, PRODUCTS OR SERVICES, INCLUDING ANY IMPLIED WARRANTY OF MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE, OR ANY WARRANTY OF NON-INFRINGEMENT OF ANY PATENT, TRADEMARK, OR OTHER INTELLECTUAL PROPERTY RIGHTS.

Credit for PRODUCTS or SERVICES

In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of, PRODUCTS or SERVICES, JACKSON will, at its option, provide credit or replacement for the PRODUCT received or the SERVICES provided; JACKSON makes no other representations and this shall be the exclusive remedy of the purchaser. Please note specific policy for live mice.

Animal Care and Use for SERVICES

Consistent with the requirement for a written understanding regarding animal care and use, the JACKSON Animal Care and Use Committee will review the animal care and use protocol(s) associated with any SERVICES to be performed at JACKSON, and JACKSON shall have ultimate responsibility and authority for the care of animals while on site or in JACKSON custody.

No Liability

In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS, or SERVICES, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. Unless prohibited by law, in purchasing or receiving MICE, PRODUCTS, or SERVICES from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.

MICE, PRODUCTS or SERVICES are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.

The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or SERVICES. In addition, special terms and conditions of sale of certain MICE, PRODUCTS, or SERVICES may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and SERVICES by JACKSON, and by its licensees and distributors.

Acceptance of delivery of MICE, PRODUCTS or SERVICES shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or SERVICES by JACKSON.

Donating Investigator

Genetic overview

Research Applications

Detailed Description

Development

Selected References

Vegfatm4Pec

Allele Symbol: Vegfatm4Pec

Disease Terms

Model with phenotypic similarity to human disease where etiologies are distinct. Human genes are associated with this disease. Orthologs of these genes do not appear in the mouse genotype(s).

Research Areas By Phenotype

This mouse can be used to support research in many areas including:

Mammalian Phenotype Terms by Genotype

Genotype: Vegfatm4Pec/Vegfatm4Pecinvolves: 129S1/Sv * 129X1/SvJ

cardiovascular system phenotype

cellular phenotype

craniofacial phenotype

embryo phenotype

growth/size/body region phenotype

mammalian phenotype

mortality/aging

reproductive system phenotype

vision/eye phenotype

References

Additional - Vegfatm4Pec related

Genotyping Protocols

Breeding Considerations

Citation

Animal Health Reports

Production of mice from cryopreserved embryos or sperm occurs in a maximum barrier room, G200

The Jackson Laboratory's Genotype Promise

Terms Of Use

Licensing Information

JAX® Mice, Products & Services Conditions of Use

No Warranty

Credit for PRODUCTS or SERVICES

Animal Care and Use for SERVICES

No Liability

Vegfa^tm4Pec

Allele Symbol: Vegfa^tm4Pec

Genotype: Vegfa^tm4Pec/Vegfa^tm4Pec
involves: 129S1/Sv * 129X1/SvJ

Additional - Vegfa^tm4Pec related